Download Sample, Increase in Needlestick Injuries Is Driving Up Demand for Safety Syringes
Needlestick injuries are potentially dangerous due to their ability to spread fatal infections like HIV and Hepatitis. As per the WHO, the increasing global burden of HIV, with 39.9 million people living with the virus in 2023 and the critical need for effective treatment and prevention, drives the demand for prefilled syringes. The urgency to reduce needlestick injuries, which can transmit infections, further propels the prefilled syringes market, emphasizing safer and more efficient drug administration methods. Moreover, both patients and physicians are at high risk of getting needle stick injuries during dosage preparation. According to the CDC, approximately 385,000 injuries from contaminated needles and other sharps devices occur every year among hospital-based healthcare personnel, which is expected to increase the business scale in the coming years.
Additionally, the Centers for Disease Control and Prevention (CDC) estimates that using safety precautions such as prefilled syringes in hospitals might cut sharps-related injuries by 60-88%. This is owing to prefilled syringes are a simple approach to reduce these injuries since their use eliminates the multiple dosage preparation steps and can be easily discarded. Innovative modifications, such as hidden needles, are helpful for avoiding such accidents in self-injection systems, resulting in greater patient convenience. Prefilled syringes ensure safety without the additional cost; therefore, their use is expected to increase in the coming years.
Additionally, the Centers for Disease Control and Prevention (CDC) estimates that using safety precautions such as prefilled syringes in hospitals might cut sharps-related injuries by 60-88%. This is owing to prefilled syringes are a simple approach to reduce these injuries since their use eliminates the multiple dosage preparation steps and can be easily discarded. Innovative modifications, such as hidden needles, are helpful for avoiding such accidents in self-injection systems, resulting in greater patient convenience. Prefilled syringes ensure safety without the additional cost; therefore, their use is expected to increase in the coming years.
Increasing Prevalence of Chronic Diseases Like Diabetes Is Likely to Boost Market Expansion
Diabetes is a severe condition that develops when the pancreas stops making insulin or when the body improperly uses the insulin that is produced. Diabetes patients commonly use prefilled syringes to give multiple doses of insulin each day. A huge patient base, rising diabetes prevalence and the demand for better and safer insulin delivery devices are some of the reasons that will aid this industry continue its dominance during the forecast period. According to the International Diabetes Federation (IDF), the number of diabetics is expected to rise to 63 million by 2030 and 783 million by 2045. Furthermore, in order to strengthen their market position, leading firms like as BD are introducing prefilled syringes developed specifically for chronic disease therapy.
An increasing number of new product launches, in addition to the aforementioned factors, is expected to actively contribute to industry development. For example, Terumo Corporation introduced a pre-fillable polymer syringe for low-dose applications in May 2022, providing a secure, practical and useful treatment alternative. In the near future, market growth will be driven by increased government spending in cutting-edge syringe manufacture. For instance, a US$ 84.53 million investment in Hungary in March 2022 is intended to cater to increasing global demand for pre-fillable glass syringes. The extension is scheduled to be completed by 2024 and is projected to fulfil the product's demand in the near future.
An increasing number of new product launches, in addition to the aforementioned factors, is expected to actively contribute to industry development. For example, Terumo Corporation introduced a pre-fillable polymer syringe for low-dose applications in May 2022, providing a secure, practical and useful treatment alternative. In the near future, market growth will be driven by increased government spending in cutting-edge syringe manufacture. For instance, a US$ 84.53 million investment in Hungary in March 2022 is intended to cater to increasing global demand for pre-fillable glass syringes. The extension is scheduled to be completed by 2024 and is projected to fulfil the product's demand in the near future.
Recent Trends in the Prefilled Syringes Industry:
- The rise in biologics and biosimilars, particularly for chronic conditions, boosts prefilled syringe demand.
- Innovations in needle design, such as finer and retractable needles, enhance safety and comfort.
- Smart prefilled syringes now feature sensors for tracking doses and reminding patients.
- Advancements in materials science are enhancing syringes with better safety and stability.
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!
Product Recalls and Complex Manufacturing Processes Will Hamper Market Growth
Prefilled syringes are becoming a more appealing alternative for complex biotechnology products. Nevertheless, several product recalls owing to contaminants or leakage in syringes limit market development throughout the forecast period. In November 2023, Nurse Assist, LLC's recall of prefilled syringes (part number 1010) highlights critical market constraints. The affected 10CC prefilled syringes, included in the recall due to sterility concerns, may undermine consumer trust and regulatory compliance. Such issues emphasize the need for rigorous quality control and risk management in the prefilled syringes sector. As a result, strict regulatory requirements, manufacturing complexity and increasing recalls of these products are major barriers to market growth.
Furthermore, the rise of alternative drug delivery systems, such as autoinjectors and wearable injectors, presents a competitive challenge by offering enhanced convenience and improved patient compliance. Additionally, prefilled syringes are often associated with shorter shelf lives, leading to higher levels of waste and increased costs for inventory management. Environmental concerns surrounding the disposal of single-use plastics further increase this issue, as improved regulations and awareness push manufacturers toward adopting more sustainable practices.
Furthermore, the rise of alternative drug delivery systems, such as autoinjectors and wearable injectors, presents a competitive challenge by offering enhanced convenience and improved patient compliance. Additionally, prefilled syringes are often associated with shorter shelf lives, leading to higher levels of waste and increased costs for inventory management. Environmental concerns surrounding the disposal of single-use plastics further increase this issue, as improved regulations and awareness push manufacturers toward adopting more sustainable practices.
Innovative Prefilled Syringes Enhance Medication Accuracy and Cold Storage for Advanced Therapies
Major industry leaders utilize strategies that focus on launching new products, merging with competitors, and purchasing companies to grow their customer base and enhance their range of products. In July 2023, Fresenius Kabi expanded its Simplist® prefilled syringe portfolio with the launch of Fentanyl Citrate Injection, USP in a 100 mcg per 2 mL formulation, the sole offering of its kind in prefilled syringes. This introduction addresses the current U.S. shortage of fentanyl citrate, enhancing patient safety by reducing administration errors and drug waste. The move underscores Fresenius Kabi's commitment to improving medication delivery efficiency and combating drug diversion in critical care environments.
Furthermore, in May 2023, SCHOTT Pharma revolutionized drug delivery with its new prefillable polymer syringes, designed to handle extreme temperatures of up to -100°C for deep-cold drug applications. This innovation supports the mRNA and gene therapy sectors, addressing the challenge of storing and transporting medications on dry ice. SCHOTT Pharma’s syringes feature advanced polymer construction and are delivered in a standardized format to streamline the filling process, backed by comprehensive scientific data on their performance in ultra-cold environments.
Furthermore, in May 2023, SCHOTT Pharma revolutionized drug delivery with its new prefillable polymer syringes, designed to handle extreme temperatures of up to -100°C for deep-cold drug applications. This innovation supports the mRNA and gene therapy sectors, addressing the challenge of storing and transporting medications on dry ice. SCHOTT Pharma’s syringes feature advanced polymer construction and are delivered in a standardized format to streamline the filling process, backed by comprehensive scientific data on their performance in ultra-cold environments.
Know Your Competitors and Strengthen Market Share Effectively
Rising Preference of Healthcare Practitioners in North America For Prefilled Injectable Devices Leads to Market Expansion
North America is estimated to have a significant market share during the forecast period due to healthcare professionals' preference for prefilled injectable devices to reduce needle-related injuries. Furthermore, key market participants such as SCHOTT group, Gerresheimer AG, Haselmeier AG, Stevanato Group and Owen Mumford Ltd are existing in the region. As a result, demand for prefilled syringes is growing in the United States, fuelling the expansion of the prefilled syringes market. According to this CDC data, more over 130 million individuals in the United States have diabetes or prediabetes. To control their blood sugar levels, patients with Type 1 diabetes receive insulin intra-venous on a regular basis. Due to their ease of use, prefilled syringes can make self-administration more practical and viable. Moreover, novel product launches and approval to the US market are expected to drive market growth throughout the forecast period. For intance, BD (Becton, Dickinson, and Company) launched a new glass pre-fillable syringe (PFS) in September 2022 with the intention of developing a new performance standard for immunisation PFS. The new BD Effivax Glass PFS was developed in partnership with pharmaceutical firms to fulfil the complex and ever-changing requirements of vaccine manufacture. As a result, such advancements in the country are likely to boost market expansion.
Searching for a Country or Region-Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
The report provides a detailed overview of the prefilled syringes market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for prefilled syringes market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the prefilled syringes market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the prefilled syringes market. Some key country and region included in the prefilled syringes market report as follows:
| Regions | Countries |
|---|---|
| North America | United States, Canada |
| Latin America | Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America |
| Europe | Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe |
| Asia Pacific | China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific |
| Middle East and Africa | GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA |
Prefilled Syringes Market Research Report Covers In-depth Analysis on:
- Prefilled syringes market detailed segments and segment-wise market breakdown
- Prefilled syringes market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in prefilled syringes industry)
- Current, historical and forthcoming 10 years market valuation in terms of prefilled syringes market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Prefilled syringes market demand analysis
- Prefilled syringes market pricing analysis over forecast period (by key segment and by region)
- Prefilled syringes market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in prefilled syringes market
- Regulatory landscape by key regions and key countries
- Supply chain and value chain analysis in prefilled syringes market
- Prefilled syringes market sales and distribution strategies
- A comprehensive overview of parent market
- A detailed viewpoint on prefilled syringes market forecast by countries
- Mergers and acquisitions in prefilled syringes market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
What are the key drivers of growth in the prefilled syringes market?
Key drivers include increasing prevalence of chronic diseases, advancements in syringe technology and growing preference for self-administered treatments.
What are the anticipated challenges for the prefilled syringes market?
Challenges include regulatory hurdles, high production costs and competition from alternative drug delivery systems, which could impact market growth and dynamics.
How will the market for prefilled syringes evolve over the next decade?
The market is expected to experience significant growth due to rising demand for convenient drug delivery solutions and technological advancements in syringe manufacturing.
What are the regional market trends for prefilled syringes?
North America and Europe currently dominate the market, but Asia Pacific is emerging as a rapidly growing region due to increasing healthcare infrastructure and rising patient populations.
